NEP inhibitors enhance C-type natriuretic peptide-induced relaxation in porcine isolated coronary artery

Vascular Pharmacology

Volumn 43, Issue 4, 2005, Pages 207-212

  Márton, Zoltán ^a   Pataricza, János ^a   Krassói, Irén ^b   Varró, András ^a   Papp, Julius Gyula ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Phosphoramidon; Porcine coronary artery; Thiorphan

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR; ENKEPHALINASE INHIBITOR; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; NATRIURETIC PEPTIDE TYPE C; PHOSPHORAMIDON; THIORPHAN; VASODILATOR AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CARDIOVASCULAR DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DILATATION; ENDOTHELIUM; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION;

ANIMALS; CORONARY VESSELS; GLYCOPEPTIDES; ISOMETRIC CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC PEPTIDE, C-TYPE; NEPRILYSIN; OLIGOPEPTIDES; PROTEASE INHIBITORS; SWINE; THIORPHAN;

EID: 27744466277     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.07.007     Document Type: Article

References (33)

1. L.K. Antos, S.E. Abbey-Hosch, D.R. Flora, and L.R. Potter ATP-independent activation of natriuretic peptide receptors J. Biol. Chem. 280 2005 26,928 26,932
2. M. Barton, J.L. Beny, L.V. d'Uscio, T. Wyss, G. Noll, and T.F. Luscher Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries J. Cardiovasc. Pharmacol. 31 1998 377 383
3. R.R. Brandt, M.T. Mattingly, A.L. Clavell, P.L. Barclay, and J.C. Burnett Jr. Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo Hypertension 30 1997 184 190
4. V.H. Casco, J.P. Veinot, M.L. Kuroski de Bold, R.G. Masters, M.M. Stevenson, and A.J. de Bold Natriuretic peptide system gene expression in human coronary arteries J. Histochem. Cytochem. 50 2002 799 809
5. S.D. Chauhan, H. Nilsson, A. Ahluwalia, and A.J. Hobbs Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor Proc. Natl. Acad. Sci. U. S. A. 100 2003 1426 1431
6. S.D. Chauhan, A.J. Hobbs, and A. Ahluwalia C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarising factor Int. J. Biochem. Cell Biol. 36 2004 1878 1881
7. H.H. Chen, and J.C. Burnett Jr. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system J. Cardiovasc. Pharmacol. 32 1998 S22 S28
8. R. Corti, J.C. Burnett Jr., J.L. Rouleau, F. Ruschitzka, and T.F. Luscher Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation 104 2001 856 862
9. C.J. Ferro, J.C. Spratt, W.G. Haynes, and D.J. Webb Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo Circulation 97 1998 2323 2330
10. W. Gonzalez, J.M. Soleilhac, M.C. Fournie-Zaluski, B.P. Roques, and J.B. Michel Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels Eur. J. Pharmacol. 345 1998 323 331
11. K. Graf, M. Grafe, C. Bossaller, J. Niehus, K.D. Schulz, W. Auch-Schwelk, and E. Fleck Degradation of bradykinin by neutral endopeptidase (EC 3.4.24.11) in cultured human endothelial cells Eur. J. Clin. Chem. Clin. Biochem. 31 1993 267 272
12. K. Graf, P. Koehne, M. Grafe, M. Zhang, W. Auch-Schwelk, and E. Fleck Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells Hypertension 26 1995 230 235
13. K. Graf, C. Schaper, M. Grafe, E. Fleck, and G. Kunkel Glucocorticoids and protein kinase C regulate neutral endopeptidase 24.11 in human vascular smooth muscle cells Basic Res. Cardiol. 93 1998 11 17
14. M.L. Honing, P. Smits, P.J. Morrison, J.C. Burnett Jr., and T.J. Rabelink C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels Hypertension 37 2001 1179 1183
15. Y. Komatsu, K. Nakao, H. Itoh, S. Suga, Y. Ogawa, and H. Imura Vascular natriuretic peptide Lancet 340 1992 622
16. Y. Komatsu, H. Itoh, S. Suga, T. Igaki, Y. Ogawa, I. Kishimoto, O. Nakagawa, T. Yoshimasa, and K.J. Nakao Regulation of secretion and clearance of C-type natriuretic peptide in the interaction of vascular endothelial cells and smooth muscle cells J. Hypertens. 14 1996 585 592
17. I. Krassoi, J. Pataricza, L.L. Torday, A. Kun, and J.G. Papp Improvement by phosphoramidon of damaged endothelial function in porcine coronary artery Ann. Thorac. Surg. 70 2000 878 882
18. N. Lapointe, and J.L. Rouleau Cardioprotective effects of vasopeptidase inhibitors Can. J. Cardiol. 18 2002 415 420
19. J.J. Maguire, C.M. Johnson, J.W. Mockridge, and A.P. Davenport Endothelin converting enzyme (ECE) activity in human vascular smooth muscle Br. J. Pharmacol. 122 1997 1647 1654
20. A.J. Maxwell, W.K. Husseini, G. Piedimonte, and J.I. Hoffman Effects of inhibiting neutral endopeptidase and kinase II on coronary and systemic hemodynamics in rats Am. J. Physiol. 269 1995 H1016 H1029
21. G. McDowell, W. Coutie, C. Shaw, K.D. Buchanan, A.D. Struthers, and D.P. Nicholls The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides Br. J. Clin. Pharmacol. 43 1997 329 332
22. K. Morishige, H. Shimokawa, T. Yamawaki, K. Miyata, Y. Eto, T. Kandabashi, K. Yogo, T. Higo, K. Egashira, H. Ueno, and A. Takeshita Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo J. Am. Coll. Cardiol. 35 2000 1040 1047
23. T. Naruko, M. Ueda, A.C. van der Wal, C.M. van der Loos, H. Itoh, K. Nakao, and A.E. Becker C-type natriuretic peptide in human coronary atherosclerotic lesions Circulation 94 1996 3103 3108
24. Q. Pu, I. Larouche, and E.L. Schiffrin Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats Am. J. Hypertens. 16 2003 931 937
25. S. Schulz C-type natriuretic peptide and guanylyl cyclase B receptor Peptides 26 2005 1024 1034
26. R.A. Skidgel, S. Engelbrecht, A.R. Johnson, and E.G. Erdös Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase Peptides 5 1984 769 776
27. J.M. Soleilhac, E. Lucas, A. Beaumont, S. Turcaud, J.B. Michel, D. Ficheux, M.C. Fournie-Zaluski, and B.P. Roques A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium Mol. Pharmacol. 41 1992 609 614
28. S. Suga, K. Nakao, H. Itoh, Y. Komatsu, Y. Ogawa, N. Hama, and H. Imura Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system" J. Clin. Invest. 90 1992 1145 1149
29. J. Vijayaraghavan, A.G. Scicli, O.A. Carretero, C. Slaughter, C. Moomaw, and L.B. Hersh The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase) J. Biol. Chem. 265 1990 14150 14155
30. L. Wang, E. Sadoun, R.E. Stephens, and P.E. Ward Metabolism of substance P and neurokinin A by human vascular endothelium and smooth muscle Peptides 15 1994 497 503
31. C.M. Wei, S.L. Hu, V.M. Miller, and J.C. Brunett Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells Biochem. Biophys. Res. Commun. 205 1994 765 771
32. K.E. Wiley, and A.P. Davenport Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery Br. J. Pharmacol. 133 2001 568 574
33. R.S. Wright, C.M. Wei, C.H. Kim, M. Kinoshita, Y. Matsuda, L.L. Aarhus, J.C. Burnett Jr., and W.L. Miller C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems J. Am. Coll. Cardiol. 28 1996 1031 1038